42nd week of 2020 patent applcation highlights part 21 |
Patent application number | Title | Published |
20200325127 | PYRIDIN-3-YL ACETIC ACID DERIVATIVES AS INHIBITORS OF HUMAN IMMUNODEFICIENCY VIRUS REPLICATION | 2020-10-15 |
20200325128 | COMPOUNDS USEFUL IN THE TREATMENT OR PREVENTION OF A PRMT5-MEDIATED DISORDER | 2020-10-15 |
20200325129 | METHODS OF TREATING NON-HODGKIN LYMPHOMA USING 2-(2,6-DIOXOPIPERIDIN-3-YL)-4-((2-FLUORO-4-((3-MORPHOLINOAZETIDIN-1-YL)ME- THYL)BENZYL)AMINO)ISOINDOLINE-1,3-DIONE | 2020-10-15 |
20200325130 | Proteolysis Targeting Chimera Compounds and Methods of Preparing and Using Same | 2020-10-15 |
20200325131 | NOVEL CRYSTALLINE SALT FORMS OF 3-(1,2,4-TRIAZOLO[4,3-A]PYRIDINE-3-YLETHYNYL)-4-METHYL-N-(4-((4-METHYLPIP- ERAZIN-1-YL)METHYL)-3-TRIFLUOROMETHYLPHENYL)BENZAMIDE FOR MEDICAL APPLICATION | 2020-10-15 |
20200325132 | TRICYCLIC COMPOUNDS FOR USE IN TREATMENT OF PROLIFERATIVE DISORDERS | 2020-10-15 |
20200325133 | TREATMENT OF OSTEOARTHRITIS | 2020-10-15 |
20200325134 | BICYCLIC HETEROCYCLE COMPOUNDS AND THEIR USES IN THERAPY | 2020-10-15 |
20200325135 | HETEROCYCLIC COMPOUNDS FOR THE TREATMENT OF DISEASE | 2020-10-15 |
20200325136 | IMMUNOMODULATORS AND IMMUNOMODULATOR CONJUGATES | 2020-10-15 |
20200325137 | IMIDAZOLONYLQUINOLINES AND THE USE THEREOF AS ATM KINASE INHIBITORS | 2020-10-15 |
20200325138 | P2X7 Modulators | 2020-10-15 |
20200325139 | NEW ANTIBIOTICS TARGETING MYCOBACTERIA | 2020-10-15 |
20200325140 | FUSED BICYCLIC COMPOUNDS FOR THE TREATMENT OF DISEASE | 2020-10-15 |
20200325141 | COMPOSITIONS AND METHODS FOR TREATING KIT- AND PDGFRA-MEDIATED DISEASES | 2020-10-15 |
20200325142 | HETEROCYCLIC COMPOUNDS AND USES THEREOF | 2020-10-15 |
20200325143 | ANTI-VIRAL DRUG | 2020-10-15 |
20200325144 | PROCESS FOR PREPARING SPIRO DERIVATIVES | 2020-10-15 |
20200325145 | MACROCYCLIC COMPOUND SERVING AS WEE1 INHIBITOR AND APPLICATIONS THEREOF | 2020-10-15 |
20200325147 | Compounds Useful in HIV Therapy | 2020-10-15 |
20200325148 | COMPOSITIONS AND METHODS OF TREATMENT FOR NEUROLOGICAL DISORDERS COMPRISING MOTOR NEURON DISEASES | 2020-10-15 |
20200325149 | TOPOISOMERASE POISONS | 2020-10-15 |
20200325150 | CRYSTAL NUCLEATING AGENT FOR POLYOLEFIN RESIN, METHOD FOR PRODUCING CRYSTAL NUCLEATING AGENT FOR POLYOLEFIN RESIN, AND METHOD FOR IMPROVING FLUIDITY OF CRYSTAL NUCLEATING AGENT FOR POLYOLEFIN RESIN | 2020-10-15 |
20200325151 | OXABICYCLOHEPTANE PRODRUGS | 2020-10-15 |
20200325152 | MACROCYCLIC COMPOUNDS AND USES THEREOF | 2020-10-15 |
20200325153 | Macrocyclic MCL-1 Inhibitors and Methods of Use | 2020-10-15 |
20200325154 | ANTIBACTERIAL BIAROMATIC DERIVATIVES WITH OXETANE-3-YLOXY SUBSTITUTION | 2020-10-15 |
20200325155 | CRYSTALLINE FORMS OF LORLATINIB MALEATE | 2020-10-15 |
20200325156 | HETEROARYL AMIDE COMPOUNDS, PREPARATION METHOD THEREFOR, PHARMACEUTICAL COMPOSITIONS THEREOF, AND APPLICATIONS THEREOF | 2020-10-15 |
20200325157 | Novel Thiophene Compounds for Long-Acting Injectable Compositions and Related Methods | 2020-10-15 |
20200325158 | METHOD FOR STORING AND/OR TRANSPORTING GALLIUM CHLORIDE | 2020-10-15 |
20200325159 | HERBICIDALLY ACTIVE BICYCLIC BENZAMIDES | 2020-10-15 |
20200325160 | GLUCOSE-SENSITIVE ALBUMIN-BINDING DERIVATIVES | 2020-10-15 |
20200325161 | HETEROCYCLIC COMPOUNDS AS ARGINASE INHIBITORS | 2020-10-15 |
20200325162 | SILYLETHYNYL HETARYL COMPOUNDS AS NITRIFICATION INHIBITORS | 2020-10-15 |
20200325163 | NOVEL ALKYLDIPHENYLMETHANE PROTECTIVE AGENT | 2020-10-15 |
20200325164 | Modifier, Method Of Preparing The Same, And Modified Conjugated Diene-Based Polymer Including The Same | 2020-10-15 |
20200325165 | Ligand Compound, Organic Chromium Compound, Catalyst System For Olefin Oligomerizatin, And Method For Oligomerizing Olefin Using Same | 2020-10-15 |
20200325166 | CRYSTALLINE FORMS OF LNT | 2020-10-15 |
20200325167 | LABELLED NUCLEOTIDES | 2020-10-15 |
20200325168 | WITHANOLIDES USEFUL FOR THE TREATMENT OF NEURODEGENERATIVE DISEASES | 2020-10-15 |
20200325169 | Methods and Devices for the Enrichment of Immunoglobulin from Blood | 2020-10-15 |
20200325170 | DERIVATIVES OF DOLAPROINE-DOLAISOLEUINE PEPTIDES | 2020-10-15 |
20200325171 | PROTEASOME INHIBITORS | 2020-10-15 |
20200325172 | Compounds for proteasome enzyme inhibition | 2020-10-15 |
20200325173 | Drug Delivery Enhancement Agents | 2020-10-15 |
20200325174 | NOVEL IMMUNOTHERAPY AGAINST SEVERAL TUMORS OF THE BLOOD, IN PARTICULAR CHRONIC LYMPHOID LEUKEMIA (CLL) | 2020-10-15 |
20200325175 | CELL-REACTIVE, LONG-ACTING, OR TARGETED COMPSTATIN ANALOGS AND RELATED COMPOSITIONS AND METHODS | 2020-10-15 |
20200325176 | Guanylate Cyclase Receptor Agonists For The Treatment Of Tissue Inflammation And Carcinogenesis | 2020-10-15 |
20200325177 | METHODS OF MAKING STREPTOGRAMIN COMPOSITIONS AND THE USE THEREOF | 2020-10-15 |
20200325178 | PEPTIDE NUCLEIC ACID MOLECULES FOR TREATMENT OF GRAM POSITIVE BACTERIAL INFECTION | 2020-10-15 |
20200325179 | ADENOVIRAL COAT PROTEIN DERIVED DELIVERY VEHICLES | 2020-10-15 |
20200325180 | VACCINES AND VACCINE COMPONENTS FOR INHIBITION OF MICROBIAL CELLS | 2020-10-15 |
20200325181 | MODIFIED VIRAL VECTORS AND METHODS OF MAKING AND USING THE SAME | 2020-10-15 |
20200325182 | ALPHAHERPESVIRUS GLYCOPROTEIN D-ENCODING NUCLEIC ACID CONSTRUCTS AND METHODS | 2020-10-15 |
20200325183 | NS2B AS MARKER FOR ZIKA VIRUS INFECTIONS | 2020-10-15 |
20200325184 | USPA2 PROTEIN CONSTRUCTS AND USES THEREOF | 2020-10-15 |
20200325185 | Recombinant Escherichia Coli and Application Thereof in Screening Erythritol-producing Strains | 2020-10-15 |
20200325186 | MODIFIED STREPTOLYSIN O | 2020-10-15 |
20200325187 | CYSTINE KNOT SCAFFOLD PLATFORM | 2020-10-15 |
20200325188 | Method for producing a condensed adhesive phase of silk fusion proteins | 2020-10-15 |
20200325189 | COLON DISEASE TARGETS AND USES THEREOF | 2020-10-15 |
20200325190 | Modification and Compositions of Human Secretoglobin Proteins | 2020-10-15 |
20200325191 | NOVEL PEPTIDES AND COMBINATION OF PEPTIDES FOR USE IN IMMUNOTHERAPY AGAINST LUNG CANCER, INCLUDING NSCLC, SCLC AND OTHER CANCERS | 2020-10-15 |
20200325192 | NOVEL PEPTIDES AND COMBINATION OF PEPTIDES FOR USE IN IMMUNOTHERAPY AGAINST LUNG CANCER, INCLUDING NSCLC, SCLC AND OTHER CANCERS | 2020-10-15 |
20200325193 | NOVEL PEPTIDES AND COMBINATION OF PEPTIDES FOR USE IN IMMUNOTHERAPY AGAINST LUNG CANCER, INCLUDING NSCLC, SCLC AND OTHER CANCERS | 2020-10-15 |
20200325194 | NOVEL PEPTIDES AND COMBINATION OF PEPTIDES FOR USE IN IMMUNOTHERAPY AGAINST OVARIAN CANCER AND OTHER CANCERS | 2020-10-15 |
20200325195 | IMMUNOTHERAPY WITH A*01 RESTRICTED PEPTIDES AND COMBINATION OF PEPTIDES AGAINST CANCERS AND RELATED METHODS | 2020-10-15 |
20200325196 | IMMUNOTHERAPY WITH A*01 RESTRICTED PEPTIDES AND COMBINATION OF PEPTIDES AGAINST CANCERS AND RELATED METHODS | 2020-10-15 |
20200325197 | IMMUNOTHERAPY WITH A*01 RESTRICTED PEPTIDES AND COMBINATION OF PEPTIDES AGAINST CANCERS AND RELATED METHODS | 2020-10-15 |
20200325198 | IMMUNOTHERAPY WITH A*01 RESTRICTED PEPTIDES AND COMBINATION OF PEPTIDES AGAINST CANCERS AND RELATED METHODS | 2020-10-15 |
20200325199 | IMMUNOTHERAPY WITH A*01 RESTRICTED PEPTIDES AND COMBINATION OF PEPTIDES AGAINST CANCERS AND RELATED METHODS | 2020-10-15 |
20200325200 | METHOD OF TREATING OR AMELIORATING METABOLIC DISORDERS USING GROWTH DIFFERENTIATION FACTOR 15 (GDF-15) | 2020-10-15 |
20200325201 | IL-2 MUTEINS AND USES THEREOF | 2020-10-15 |
20200325202 | IL-2 MUTEINS AND USES THEREOF | 2020-10-15 |
20200325203 | SYNTHETIC SOMATOSTATIN RECEPTOR LIGANDS | 2020-10-15 |
20200325204 | VESICULAR STOMATITIS VIRUSES | 2020-10-15 |
20200325205 | METHODS FOR MODULATING AN IMMUNE RESPONSE | 2020-10-15 |
20200325206 | NOVEL PEPTIDES AND COMBINATION OF PEPTIDES FOR USE IN IMMUNOTHERAPY AGAINST VARIOUS TUMORS | 2020-10-15 |
20200325207 | NOVEL PEPTIDES, COMBINATION OF PEPTIDES AS TARGETS AND FOR USE IN IMMUNOTHERAPY AGAINST GALLBLADDER CANCER AND CHOLANGIOCARCINOMA AND OTHER CANCERS | 2020-10-15 |
20200325208 | VEGFR-ANTIBODY LIGHT CHAIN FUSION PROTEIN | 2020-10-15 |
20200325209 | HUMAN SERUM ALBUMIN VARIANTS AND USES THEREOF | 2020-10-15 |
20200325210 | CYSTEINE ENGINEERED FIBRONECTIN TYPE III DOMAIN BINDING MOLECULES | 2020-10-15 |
20200325211 | RECOMBINANT ELASTIN AND PRODUCTION THEREOF | 2020-10-15 |
20200325212 | TUMOR-SELECTIVE CTLA-4 ANTAGONISTS | 2020-10-15 |
20200325213 | RSV-SPECIFIC BINDING MOLECULES AND MEANS FOR PRODUCING THEM | 2020-10-15 |
20200325214 | NOVEL ANTI-HSA ANTIBODIES | 2020-10-15 |
20200325215 | COMPOSITIONS AND METHODS OF USE FOR DETERMINATION OF HE4a | 2020-10-15 |
20200325216 | AB6 FAMILY DESIGNER LIGANDS OF TGF-BETA SUPERFAMILY | 2020-10-15 |
20200325217 | SULFONATED SCLEROSTIN, ANTIBODIES, EPITOPES AND METHODS FOR IDENTIFICATION AND USE THEREFOR | 2020-10-15 |
20200325218 | THYMIC STROMAL LYMPHOPOIETIN (TSLP)-BINDING MOLECULES AND METHODS OF USING THE MOLECULES | 2020-10-15 |
20200325219 | ANTI-TRAIL ANTIBODIES AND METHODS OF USE | 2020-10-15 |
20200325220 | ANTIBODIES WITH FUNCTIONAL DOMAINS IN THE ELBOW REGION BETWEEN VARIABLE AND CONSTANT DOMAIN | 2020-10-15 |
20200325221 | TECHNIQUES FOR PREDICTING, DETECTING AND REDUCING ASPECIFIC PROTEIN INTERFERENCE IN ASSAYS INVOLVING IMMUNOGLOBULIN SINGLE VARIABLE DOMAINS | 2020-10-15 |
20200325222 | CANCER STEM CELL-SPECIFIC MOLECULE | 2020-10-15 |
20200325223 | METHODS OF TREATMENTS USING ANTIGEN-BINDING PROTEINS TARGETING CD56 | 2020-10-15 |
20200325224 | ANTIBODIES BINDING TO HUMAN AND CYNOMOLGUS CD3 EPSILON | 2020-10-15 |
20200325225 | COMBINATION THERAPY WITH TARGETED 4-1BB (CD137) AGONISTS | 2020-10-15 |
20200325226 | ANTI-PD-1 ANTIBODY FOR USE IN A METHOD OF TREATING A TUMOR | 2020-10-15 |
20200325227 | BINDING MOLECULES THAT MODULATE A BIOLOGICAL ACTIVITY EXPRESSED BY A CELL | 2020-10-15 |